Skip to content

Nurse-led dyadic intervention on treatment adherence

Effect of nurse-led dyadic intervention on treatment adherence of inpatients receiving clozapine therapy at NIMHANS, Bengaluru - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079804
Enrollment
70
Registered
2025-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G- Mental Health

Interventions

Intervention1: Nurse-led-Dyadic Intervention: The Nurse-led Dyadic Intervention includes nurse-led counseling sessions conducted over three consecutive days, lasting one hour each day, for patients in

Sponsors

National Institute of Mental Health and Neurosciences (NIMHANS)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inpatients o All genders o Patients diagnosed with schizophrenia and newly initiated on clozapine therapy. o Between the age of 18-60 years. o Patients who can understand Hindi and English. o Patients accompanied by informal caregivers who will be actively involved in patient care on a day-to-day basis for at least six months. Informal caregiver o All genders o Informal caregivers aged above 18 years. o Informal caregivers who can understand Hindi and English o Informal caregivers who are willing to regularly monitor pill card, investigation card, communicate with the researcher by phone once in every two weeks and actively involved in management and reporting of side effects.

Exclusion criteria

Exclusion criteria: Patient o Patients diagnosed with co-morbid intellectual disability. Informal caregiver o Informal caregivers with severe psychiatric or neurological disorders. o Informal caregivers with any sensory deficits.

Design outcomes

Primary

MeasureTime frame
Adherence to medicationTimepoint: Three months and six months

Secondary

MeasureTime frame
Attitude towards medication, anthropometric measurements, haematological profile, biochemical profile, adherence to WBC monitoring, severity of illness, quality of life, socio occupational functioning, family burdenTimepoint: 3 months and 6 months

Countries

India

Contacts

Public ContactDr Sailaxmi Gandhi

National Institute of Mental Health and Neurosciences (NIMHANS)

sailaxmi63@yahoo.com9902763889

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026